Towards an effective gene therapy for idiopathic pulmonary fibrosis: anti-inflammation, antifibrosis, and regeneration.
Ebina
Masahito
M
Respiratory Oncology and Molecular Medicine, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan. ebinam@idac.tohoku.ac.jp
Shimizukawa
M
M
Narumi
K
K
Miki
M
M
Koinuma
D
D
Watanabe
M
M
Munakata
H
H
Nukiwa
T
T
D000818:Animals; D058575:Decorin; D016326:Extracellular Matrix Proteins; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D017228:Hepatocyte Growth Factor / Q000235:genetics; D008168:Lung / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D011509:Proteoglycans / Q000235:genetics; D011658:Pulmonary Fibrosis / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D012038:Regeneration; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors
C546879:Dcn protein, mouse; D058575:Decorin; D016326:Extracellular Matrix Proteins; D011509:Proteoglycans; D016212:Transforming Growth Factor beta; D017228:Hepatocyte Growth Factor